Institute for International Research

The only Oncology conference focused on the design & management of clinical trials

Offering a Brand New On-Site Experience!
Co-located with the Partnerships with CROs event, enjoy networking opportunities with over 1,800 clinical professionals. As an attendee, you have access to over 200 exhibit booths, refreshments, luncheons and networking receptions.

Check out what this information packed event will offer you:

• Map out a DRUG DEVELOPMENT strategy designed to hit the market
  
• Learn how ADAPTIVE CLINICAL TRIAL design can be applied in oncology for earlier clinical trials
• Understand how clinical trial design and drug development need to be adapted for TARGETED THERAPIES
• Gain the latest information on using BIOMARKERS as endpoints to ease the process of developing effective and safe oncologic drugs
• Hear what new ENDPOINTS might be considered for use in clinical trials
• Preserve the quality of your trial data through understanding the use of IMAGING
• Navigate the complexities of conducting GLOBAL TRIALS in Asia

Hear from top pharma, biotech, and academia presenters as they lend their expertise:

Debasish Roychowdhury, MD, Vice President, Clinical Drug Development, GLAXOSMITHKLINE
Walter P. Carney, MD, Head of Oncogene Science, BAYER HEALTHCARE
Howard Fingert, Senior Director, Clinical Lead, Signal Transduction Development Program, Pfizer Oncology, PFIZER GLOBAL R&D
Nancy Davenport-Ennis, CEO, PATIENT ADVOCATE FOUNDATION and NATIONAL PATIENT ADVOCATE FOUNDATION
Renee B Iacona, PhD, MPH, Global Product Statistician, ASTRAZENECA PHARMACEUTICALS
Michael Schuster, MD, Director of Clinical Trials, Division of Hematology/Oncology, NEW YORK PRESBYTERIAN HOSPITAL
Darrel P. Cohen, M.D., Ph.D., Senior Director, Oncology Clinical Development, PFIZER GLOBAL RESEARCH AND DEVELOPMENT

Pre-Conference Full Day Symposium
Patient Accrual for Oncology Trials - Mitigate the burden of enrolling patients in your clinical trial with one of the leading patient-recruiting Oncologists

Register today to attend the only conference designed to reduce the time and cost of conducting Oncology trials.